01 8Onfi
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 104
2019 Revenue in Millions : 171
Growth (%) : -39
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 77
2020 Revenue in Millions : 103
Growth (%) : -21
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 61
2021 Revenue in Millions : 77
Growth (%) : -20
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 138
2014 Revenue in Millions : 264
Growth (%) : 91%
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : 61%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 514
2016 Revenue in Millions : 410
Growth (%) : 25
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 475
2017 Revenue in Millions : 453
Growth (%) : 5%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 158
2018 Revenue in Millions : 475
Growth (%) : -67
LOOKING FOR A SUPPLIER?